MedPath

Cetrorelix

Generic Name
Cetrorelix
Brand Names
Cetrotide
Drug Type
Small Molecule
Chemical Formula
C70H92ClN17O14
CAS Number
120287-85-6
Unique Ingredient Identifier
OON1HFZ4BA

Overview

Cetrorelix is a man-made hormone that blocks the effects of Gonadotropin Releasing Hormone (GnRH). GnRH controls another hormone that is called luteinizing hormone (LH), which is the hormone that starts ovulation during the menstrual cycle. When undergoing hormone treatment sometimes premature ovulation can occur, leading to eggs that are not ready for fertilization to be released. Cetrorelix does not allow the premature release of these eggs to occur.

Indication

For the inhibition of premature LH surges in women undergoing controlled ovarian stimulation

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/03/11
Phase 3
Completed
Kasr El Aini Hospital
2024/09/23
Phase 1
Completed
Ahmed Saad
2024/04/22
Not Applicable
Recruiting
Mỹ Đức Hospital
2023/09/05
Not Applicable
Recruiting
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
2023/08/02
Phase 3
Recruiting
2023/07/19
Phase 2
Not yet recruiting
2023/03/02
Not Applicable
Recruiting
2023/02/22
Phase 2
Not yet recruiting
Bio Genuine (Shanghai) Biotech Co., Ltd.
2021/11/09
Not Applicable
UNKNOWN
2021/08/06
Phase 4
UNKNOWN

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
CETROTIDE INJECTION 0.25 mg
SIN11345P
INJECTION
0.25 mg
7/10/2000

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
CEZIBOE 0,25 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
85838
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Diagnóstico Hospitalario
Commercialized
CETROTIDE 0,25 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
99100002
POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE
Diagnóstico Hospitalario
Not Commercialized
CETROTIDE 0,25 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
99100001
POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE
Diagnóstico Hospitalario
Not Commercialized
CETRORELIX EDEST 0,25 MG POLVO PARA SOLUCION INYECTABLE
Intas Third Party Sales 2005 S.L.
85740
POLVO PARA SOLUCIÓN INYECTABLE
Diagnóstico Hospitalario
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.